Phenylephrine or Norepinephrine for a Better Hemodynamic Stability

NCT ID: NCT03215797

Last Updated: 2018-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-09-30

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective, double-blinded study. The present study consisted in applying Stroke volume variation fluid guided therapy to old patients (65 years old) undergoing radical resection of colon surgery. The aim of this study is to compare the effects of norepinephrine and phenylephrine in treating perioperative hypotension, and to find the safest and most effective vasopressor for elderly.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fluid management has a great influence on patient's morbidity, mortality and on the overall outcome.Goal directed therapy was proved by multiple studies to be a goal therapy in maintaining a stable hemodynamic state. Nevertheless, as the population worldwide is aging, elderly presenting for surgery are also increasing. This population is known for the multiple comorbidities and physiological changes which makes them prone to dehydration and hypotension. That's when we are going to use either Norepinephrine in one group or Phenylephrine in the other and compare the effects of both vasopressors.

Parameters we are going to use are: Hemodynamic (HR, MAP, CO, CI, SVV, SV); Tissue Oxygenation and perfusion (DO2, VO2, ERO2, CRT, Lactate, blood gas); Urine output.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypotension Fluid Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

phenylephrine and norepinephrine

Phenylephrine 100ug/ml and Norepinephrine 5ug/ml IV infusion at a rate of 5 ml/h in case of perioperative hypotension.

Group Type ACTIVE_COMPARATOR

phenylephrine

Intervention Type DRUG

phenylephrine 100ug/ml IV infusion at a rate of 5ml/h in case of hypotension.

Norepinephrine

Intervention Type DRUG

Norepinephrine 5ug/ml IV infusion at a rate of 5 ml/h in case of hypotension

Norepinephrine and phenylephrine

Phenylephrine 100ug/ml and Norepinephrine 5ug/ml IV infusion in postoperative time in case of hypotension

Group Type OTHER

phenylephrine

Intervention Type DRUG

phenylephrine 100ug/ml IV infusion at a rate of 5ml/h in case of hypotension.

Norepinephrine

Intervention Type DRUG

Norepinephrine 5ug/ml IV infusion at a rate of 5 ml/h in case of hypotension

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

phenylephrine

phenylephrine 100ug/ml IV infusion at a rate of 5ml/h in case of hypotension.

Intervention Type DRUG

Norepinephrine

Norepinephrine 5ug/ml IV infusion at a rate of 5 ml/h in case of hypotension

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

α1-adrenergic receptor agonist vasopressor noradrenaline catecholamine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Operation time should be equal or greater than 2h,
* Patients older than 65 years old,
* ASA Ⅱ or Ⅲ.

Exclusion Criteria

* Clear arrhythmia,
* Need to apply PEEP,
* Peripheral vascular disease and arterial catheter contraindications.
Minimum Eligible Age

60 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Second Affiliated Hospital of Dalian Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Ph Vs N in SVV GDT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phenylephrine and Pulse Pressure Variability
NCT05011357 COMPLETED EARLY_PHASE1
Parameters of Cerebral Perfusion
NCT02806492 COMPLETED NA